Substituted carboranes and polyhedral hydroborate salts as anti-neoplastics

I H Hall1, A Elkins, W J Powell

  • 1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360, USA.

Anticancer Research
|August 15, 1998
PubMed

Insights

Substituted carboranes show potent anti-cancer activity against various leukemias and solid tumors. These compounds, like amino-o-carborane-hydrochloride 7, target DNA synthesis by inhibiting key enzymes in purine synthesis.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Biochemistry

Background:

  • Substituted carboranes and polyhedral hydroborate salts exhibit anti-neoplastic and cytotoxic properties.
  • These compounds have demonstrated efficacy against a range of cancers, including leukemias, adenocarcinomas, and gliomas.

Purpose of the Study:

  • To investigate the anti-cancer potential of substituted carboranes and polyhedral hydroborate salts.
  • To elucidate the mechanism of action of potent compounds like amino-o-carborane-hydrochloride 7 on cancer cell DNA synthesis.

Main Methods:

  • In vitro assessment of cytotoxic and anti-neoplastic activity against various cancer cell lines.
  • Analysis of the effects of amino-o-carborane-hydrochloride 7 on DNA synthesis in Tmolt3 cells.
  • Enzyme activity assays to determine the inhibition targets of the carborane compounds.

Main Results:

  • Amino-o-carborane-hydrochloride 7 preferentially inhibited Tmolt3 DNA synthesis.
  • The compound targeted de novo purine synthesis by inhibiting PRPP-amido transferase and inosine monophosphate dehydrogenase.
  • Dihydrofolate reductase and nucleoside kinase activities were also inhibited, leading to reduced deoxyribonucleotide pools.

Conclusions:

  • Substituted carboranes are effective anti-cancer agents targeting critical enzymes in nucleotide biosynthesis.
  • Amino-o-carborane-hydrochloride 7 represents a promising lead compound for further development in cancer therapy.
  • The mechanism involves disruption of DNA synthesis through inhibition of purine and pyrimidine pathways.